ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

317
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
30 Dec 2024 14:43

GAPack (468 HK): Hong Kong's Takeovers Code Needs A PUSU Rule

It's ~21 weeks since co-founders Jeff Bi and Gang Hong tabled a non-binding Offer. With no firm Offer in sight, AND contesting a SAMR ruling, they...

Logo
789 Views
Share
bullishESR Group
30 Dec 2024 01:26

Merger Arb Mondays (30 Dec) - ESR, Canvest, Vesync, GAPack, SDHS New Energy, CPMC, Makino, Arcadium

This week, the highest gross spreads are Vesync (33.3%), Makino Milling (18.9%), Seven & I (16.0%), Arcadium Lithium (14.0%), Get Nice Financial...

Logo
585 Views
Share
bullishHonda Motor
29 Dec 2024 06:45

Last Week in Event SPACE: Honda, Shanghai Henlius, Exedy, Arcadium Lithium

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
635 Views
Share
29 Dec 2024 06:30

(Mostly) Asia-Pac M&A: Makino, Henlius, GAPack, Nec Networks, Suntec REIT, VCredit, Pentamaster

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
562 Views
Share
bullishSuntec REIT
24 Dec 2024 11:38

Suntec REIT (SUN SP): Tang's Offer Now Open

This appears an obligatory MGO.  I wouldn't expect the Tangs to extend beyond the First Close.  Suntec is not expensive at 0.6x P/B. But I don't...

Logo
797 Views
Share
x